A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

Exclusion Criteria

• •Have total ankylosis of the spine.
• •Have never taken a TNF inhibitor medication or have taken more than 2.
• •Have recently received a live vaccine within 12 weeks or have had a vaccination with Bacillus Calmette-Guerin (BCG) within the past year.
• •Have an ongoing or serious infection within the last 12 weeks or evidence of active tuberculosis.
• •Have a compromised immune system.
• •Have any other serious and/or uncontrolled diseases.
• •Have either a current diagnosis or a recent history of malignant disease.
• •Have had major surgery within 8 weeks of baseline, or will require surgery during the study.
• •Are pregnant or breastfeeding.